Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
It May Take a Year to Restore Abu Dhabi Aluminum Output, EGA Says- A top Marine shares his secrets to keeping fit at 50
- Heavenly Pastry Confrontation: Pick Your #1 Sweet Treat!
- 37 Things Just Individuals Experiencing childhood during the 80s Will Comprehend
- Blue Origin’s New Glenn rocket landed its booster on a barge at sea – an achievement that will broaden the commercial spaceflight market
- Instructions to Guarantee Kids Foster Solid Dental Propensities
- Israel intensifies Lebanon attacks and hits areas not in Hezbollah's control
- This is Countdown, CNN’s newsletter covering NASA’s first time sending humans to deep space in over 50 years
- Instructions to Perform Fundamental Upkeep on Your Slam 1500.
